| Harold Thompson, DO | |
|
2nd Floor Parks Hall, Athens, OH 45701 | |
| (740) 593-2456 | |
| (740) 593-9630 |
| Full Name | Harold Thompson |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 48 Years |
| Location | 2nd Floor Parks Hall, Athens, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447252077 | NPI | - | NPPES |
| 0361059 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 34-002658T (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohiohealth Corporation | 6305758426 | 1900 |
News Archive
Inviragen has received a $600,000 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to partially support its continued efforts to develop a safe and effective dengue vaccine. The two-year grant will fund a collaborative effort led by Inviragen and involving scientists at the University of Wisconsin and Division of Vector-Borne Infectious Diseases at the Centers for Disease Control and Prevention (CDC). The supported work will include additional optimization of Inviragen's vaccine to generate more potent immune responses.
Micromet, Inc. today outlined a clinical development plan intended to support U.S. registration of its lead product candidate blinatumomab in patients with B-precursor relapsed/refractory (r/r) acute lymphoblastic leukemia.
microDimensions announced today that the United States Patent and Trademark Office has issued the US Patent 2015/0016703 A1 for its method for image registration of sections, in particular of histological sections. The patented technology enables fast and accurate alignment of whole slide and other large images up to the scanned resolution.
Pain medicine physicians from the American Academy of Pain Medicine (AAPM) continued to advance the call for better pain care as they joined with physician leaders from across the country in a closed-door National Pain Summit that took place adjacent to an AMA meeting last week in Houston, Texas.
› Verified 1 days ago
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
Inviragen has received a $600,000 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to partially support its continued efforts to develop a safe and effective dengue vaccine. The two-year grant will fund a collaborative effort led by Inviragen and involving scientists at the University of Wisconsin and Division of Vector-Borne Infectious Diseases at the Centers for Disease Control and Prevention (CDC). The supported work will include additional optimization of Inviragen's vaccine to generate more potent immune responses.
Micromet, Inc. today outlined a clinical development plan intended to support U.S. registration of its lead product candidate blinatumomab in patients with B-precursor relapsed/refractory (r/r) acute lymphoblastic leukemia.
microDimensions announced today that the United States Patent and Trademark Office has issued the US Patent 2015/0016703 A1 for its method for image registration of sections, in particular of histological sections. The patented technology enables fast and accurate alignment of whole slide and other large images up to the scanned resolution.
Pain medicine physicians from the American Academy of Pain Medicine (AAPM) continued to advance the call for better pain care as they joined with physician leaders from across the country in a closed-door National Pain Summit that took place adjacent to an AMA meeting last week in Houston, Texas.
› Verified 1 days ago
| Entity Name | Athens Medical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982714358 PECOS PAC ID: 9537112685 Enrollment ID: O20050301000331 |
News Archive
Inviragen has received a $600,000 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to partially support its continued efforts to develop a safe and effective dengue vaccine. The two-year grant will fund a collaborative effort led by Inviragen and involving scientists at the University of Wisconsin and Division of Vector-Borne Infectious Diseases at the Centers for Disease Control and Prevention (CDC). The supported work will include additional optimization of Inviragen's vaccine to generate more potent immune responses.
Micromet, Inc. today outlined a clinical development plan intended to support U.S. registration of its lead product candidate blinatumomab in patients with B-precursor relapsed/refractory (r/r) acute lymphoblastic leukemia.
microDimensions announced today that the United States Patent and Trademark Office has issued the US Patent 2015/0016703 A1 for its method for image registration of sections, in particular of histological sections. The patented technology enables fast and accurate alignment of whole slide and other large images up to the scanned resolution.
Pain medicine physicians from the American Academy of Pain Medicine (AAPM) continued to advance the call for better pain care as they joined with physician leaders from across the country in a closed-door National Pain Summit that took place adjacent to an AMA meeting last week in Houston, Texas.
› Verified 1 days ago
| Entity Name | Ohiohealth Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811207160 PECOS PAC ID: 3476733700 Enrollment ID: O20110203000715 |
News Archive
Inviragen has received a $600,000 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to partially support its continued efforts to develop a safe and effective dengue vaccine. The two-year grant will fund a collaborative effort led by Inviragen and involving scientists at the University of Wisconsin and Division of Vector-Borne Infectious Diseases at the Centers for Disease Control and Prevention (CDC). The supported work will include additional optimization of Inviragen's vaccine to generate more potent immune responses.
Micromet, Inc. today outlined a clinical development plan intended to support U.S. registration of its lead product candidate blinatumomab in patients with B-precursor relapsed/refractory (r/r) acute lymphoblastic leukemia.
microDimensions announced today that the United States Patent and Trademark Office has issued the US Patent 2015/0016703 A1 for its method for image registration of sections, in particular of histological sections. The patented technology enables fast and accurate alignment of whole slide and other large images up to the scanned resolution.
Pain medicine physicians from the American Academy of Pain Medicine (AAPM) continued to advance the call for better pain care as they joined with physician leaders from across the country in a closed-door National Pain Summit that took place adjacent to an AMA meeting last week in Houston, Texas.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harold Thompson, DO 2nd Floor Parks Hall, Athens, OH 45701 Ph: (740) 593-2456 | Harold Thompson, DO 2nd Floor Parks Hall, Athens, OH 45701 Ph: (740) 593-2456 |
News Archive
Inviragen has received a $600,000 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to partially support its continued efforts to develop a safe and effective dengue vaccine. The two-year grant will fund a collaborative effort led by Inviragen and involving scientists at the University of Wisconsin and Division of Vector-Borne Infectious Diseases at the Centers for Disease Control and Prevention (CDC). The supported work will include additional optimization of Inviragen's vaccine to generate more potent immune responses.
Micromet, Inc. today outlined a clinical development plan intended to support U.S. registration of its lead product candidate blinatumomab in patients with B-precursor relapsed/refractory (r/r) acute lymphoblastic leukemia.
microDimensions announced today that the United States Patent and Trademark Office has issued the US Patent 2015/0016703 A1 for its method for image registration of sections, in particular of histological sections. The patented technology enables fast and accurate alignment of whole slide and other large images up to the scanned resolution.
Pain medicine physicians from the American Academy of Pain Medicine (AAPM) continued to advance the call for better pain care as they joined with physician leaders from across the country in a closed-door National Pain Summit that took place adjacent to an AMA meeting last week in Houston, Texas.
› Verified 1 days ago
Peter B Dane, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 2nd Floor Parks Hall, Athens, OH 45701 Phone: 740-593-2456 Fax: 740-593-9630 | |
Timothy J. Hogan, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 265 W Union St, Suite A, Athens, OH 45701 Phone: 740-594-2456 Fax: 740-594-9630 | |
Dr. David Stanley Drozek, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 26 E Park Dr Ste 105, Athens, OH 45701 Phone: 740-592-4229 Fax: 740-592-4010 | |
Martha A Simpson, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 265 W Union St, Suite B, Athens, OH 45701 Phone: 740-594-2456 Fax: 740-594-9630 | |
Christopher Simpson, DO General Practice Medicare: Not Enrolled in Medicare Practice Location: 265 W Union St, Suite B, Athens, OH 45701 Phone: 740-594-2456 Fax: 740-594-9630 | |
John Dennis Cunningham, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2 Health Center Dr, Athens, OH 45701 Phone: 740-593-1660 Fax: 740-593-0179 |